Vaccine hesitancy decreases, long term concerns remain in myositis, rheumatic disease patients: A comparative analysis of the COVAD surveys.
Parikshit SenNaveen RNazanin HoushmandSiamak Moghadam KiaMasataka KuwanaSreoshy SahaKshitij JagtapVishwesh AgarwalAlbert Selva-O'CallaghanElena NikiphorouAi Lyn TanSamuel Katsuyuki ShinjoNelly ZiadéTsvetelina V VelikovaMarcin MilchertIoannis ParodisAbraham Edgar Gracia-RamosLorenzo CavagnaMasataka KuwanaJohannes KnitzaAshima MakolAarat PatelJohn D PaulingChris WincupBhupen BarmanErick Adrian Zamora TehozolJorge Rojas SerranoIgnacio García-De La TorreIris Jazmin Colunga-PedrazaFrancisco Javier Merayo-ChalicoOkwara Celestine ChibuzoWanrachada KatchamartPhonpen Akawatcharangura GooRusska ShumnalievaYi Ming ChenLeonardo Santos HoffEl Lina KibbiHussein HalabiBinit VaidyaSyahrul Sazliyana ShaharirA T M Tanveer HasanDzifa DeyCarlos Enrique Toro GutiérrezCarlo Vinicio Caballero-UribeJames B LillekerBabur SalimTamer A GheitaTulika ChatterjeeOliver DistlerMiguel Ángel Saavedra-SalinasJessica A DayGabriela Arredondo Hector Chinoynull nullVikas AgarwalRohit AggarwalLatika GuptaPublished in: Rheumatology (Oxford, England) (2023)
Vaccine hesitancy has decreased from 2021 to 2022, long-term safety concerns remain among patients with IIMs, particularly in Caucasians and those with poor physical function.